| Gender |
|
|
| Male |
45.7% |
16/35 |
| Female |
54.3% |
19/35 |
| Indifferent |
0% |
0/35 |
| Unknown |
0% |
0/35 |
| General |
|
|
| Birth Length abnormalities |
8.6% |
3/35 |
| < P3 : Birth length less than 3rd percentile |
8.6% |
3/35 |
| Birth Weight abnormalities |
14.3% |
5/35 |
| < P3 : Small for gestational age |
11.4% |
4/35 |
| > P98 : Large for gestational age |
2.9% |
1/35 |
| Birth Head circumference abnormalities |
8.6% |
3/35 |
| > P98 : Macrocephaly at birth |
2.9% |
1/35 |
| < P3 : Primary microcephaly |
5.7% |
2/35 |
| Current Height abnormalities |
20.0% |
7/35 |
| < P3 : Short stature |
20.0% |
7/35 |
| Current Weight abnormalities |
14.3% |
5/35 |
| < P3 : Decreased body weight |
11.4% |
4/35 |
| > P98 : Increased body weight |
2.9% |
1/35 |
| Current Head circumference abnormalities |
5.7% |
2/35 |
| > P98 : Macrocephaly |
2.9% |
1/35 |
| < P3 : Microcephaly |
2.9% |
1/35 |
| Neurology |
|
|
| Neurological abnormalities |
100.0% |
35/35 |
| Motor delay |
91.4% |
32/35 |
| Generalized hypotonia |
80.0% |
28/35 |
| Delayed speech and language development |
77.1% |
27/35 |
| Ataxia |
54.3% |
19/35 |
| Gait ataxia |
40.0% |
14/35 |
| Dysarthria |
20.0% |
7/35 |
| EEG abnormality |
17.1% |
6/35 |
| Incoordination |
17.1% |
6/35 |
| Febrile seizure (within the age range of 3 months to 6 years) |
11.4% |
4/35 |
| Hypomimic face |
11.4% |
4/35 |
| Seizure |
8.6% |
3/35 |
| Myopathy |
5.7% |
2/35 |
| Speech apraxia |
5.7% |
2/35 |
| Hypertonia |
2.9% |
1/35 |
| Language impairment |
2.9% |
1/35 |
| Moderate intellectual disability |
2.9% |
1/35 |
| Neurodevelopmental delay |
2.9% |
1/35 |
| obsolete Difficulty walking |
2.9% |
1/35 |
| Behavioral problems |
100.0% |
14/14 |
| Attention deficit hyperactivity disorder |
42.9% |
6/14 |
| Autistic behavior |
42.9% |
6/14 |
| Motor stereotypy |
28.6% |
4/14 |
| Autism |
21.4% |
3/14 |
| Emotional lability |
14.3% |
2/14 |
| Low frustration tolerance |
7.1% |
1/14 |
| Motor tics |
7.1% |
1/14 |
| Brain abnormality |
35.7% |
10/28 |
| Abnormal cerebellum morphology |
28.6% |
8/28 |
| Cerebellar vermis hypoplasia |
21.4% |
6/28 |
| Delayed myelination |
7.1% |
2/28 |
| Abnormal cerebral ventricle morphology |
3.6% |
1/28 |
| Facial abnormalities |
|
|
| Abnormality of the ear |
73.3% |
11/15 |
| Low-set ears |
6.7% |
1/15 |
| Abnormality of the eye |
100.0% |
23/23 |
| Strabismus |
91.3% |
21/23 |
| Nystagmus |
8.7% |
2/23 |
| Almond-shaped palpebral fissure |
4.3% |
1/23 |
| Broad eyebrow |
4.3% |
1/23 |
| Synophrys |
4.3% |
1/23 |
| Abnormality of the nose |
87.5% |
7/8 |
| Abnormal nasal bridge morphology |
62.5% |
5/8 |
| Anteverted nares |
25.0% |
2/8 |
| Abnormality of the mouth |
100.0% |
13/13 |
| Abnormal lip morphology |
92.3% |
12/13 |
| Delayed eruption of permanent teeth |
7.7% |
1/13 |
| High palate |
7.7% |
1/13 |
| Long uvula |
7.7% |
1/13 |
| Visual and hearing impairments |
|
|
| Abnormal vision |
100.0% |
1/1 |
| Strabismus |
100.0% |
1/1 |
| Gastrointestinal |
|
|
| Gastrointestinal abnormalities |
91.7% |
11/12 |
| Feeding difficulties |
66.7% |
8/12 |
| Constipation |
33.3% |
4/12 |
| Gastroesophageal reflux |
33.3% |
4/12 |
| Urogenital |
|
|
| Abnormality of the urogenital system |
94.7% |
18/19 |
| Neurogenic bladder |
47.4% |
9/19 |
| Recurrent urinary tract infections |
42.1% |
8/19 |
| Vesicoureteral reflux |
42.1% |
8/19 |
| Abnormal external genitalia morphology |
31.6% |
6/19 |
| Abnormality of the bladder |
26.3% |
5/19 |
| Abnormality of the kidney |
26.3% |
5/19 |
| Cryptorchidism |
15.8% |
3/19 |
| Abnormal female reproductive system physiology |
10.5% |
2/19 |
| Skeleton |
|
|
| Skeletal abnormalities |
96.2% |
25/26 |
| Short stature |
53.8% |
14/26 |
| Abnormal forehead morphology |
30.8% |
8/26 |
| Prominent forehead |
26.9% |
7/26 |
| Broad chin |
23.1% |
6/26 |
| Long face |
23.1% |
6/26 |
| Short chin |
23.1% |
6/26 |
| Triangular face |
23.1% |
6/26 |
| Abnormal nasal bridge morphology |
15.4% |
4/26 |
| Pectus excavatum |
15.4% |
4/26 |
| Clinodactyly |
7.7% |
2/26 |
| Pointed chin |
7.7% |
2/26 |
| Short digit |
7.7% |
2/26 |